MARKET

CRSP

CRSP

Crispr Therapeut
NASDAQ
51.64
-0.81
-1.54%
After Hours: 52.00 +0.36 +0.70% 17:07 08/06 EDT
OPEN
52.55
PREV CLOSE
52.45
HIGH
53.11
LOW
51.51
VOLUME
1.02M
TURNOVER
--
52 WEEK HIGH
78.48
52 WEEK LOW
44.12
MARKET CAP
4.99B
P/E (TTM)
-10.8483
1D
5D
1M
3M
1Y
5Y
1D
Crispr Therapeutics price target raised to $55 from $48 at Goldman Sachs
TipRanks · 7h ago
Prime Medicine Q2 net loss narrows on lower expenses
Reuters · 8h ago
Goldman Sachs Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP)
TipRanks · 9h ago
CORRECTED-Switzerland's Roivant Q1 loss widens
Reuters · 9h ago
Switzerland's Roivant Q1 loss widens
Reuters · 9h ago
Precision BioSciences Q2 net loss widens on warrant liability charge
Reuters · 9h ago
Intellia Therapeutics Q2 collaboration revenue falls, net loss widens
Reuters · 9h ago
RBC Capital Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP)
TipRanks · 19h ago
More
About CRSP
CRISPR Therapeutics AG is a Switzerland-based gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) and is a technology for gene editing, the process of precisely altering specific sequences of genomic DNA. The Company aims to apply this technology to disrupt, delete, correct and insert genes to treat genetically-defined diseases and to engineer advanced cellular therapies. The Company has acquired the rights to the intellectual property (IP) encompassing CRISPR/Cas9 and related technologies and is also involved in its own IP research and additional in-licensing efforts. The Company product development and partnership strategies are designed to exploit the full potential of the CRISPR/Cas9 platform while maximizing the probability of successfully developing their product candidates.

Webull offers Crispr Therapeutics AG stock information, including NASDAQ: CRSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CRSP stock methods without spending real money on the virtual paper trading platform.